These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 20440378)

  • 1. Accelerator mass spectrometry-enabled studies: current status and future prospects.
    Arjomand A
    Bioanalysis; 2010 Mar; 2(3):519-41. PubMed ID: 20440378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological and biomedical (14)C-accelerator mass spectrometry and graphitization of carbonaceous samples.
    Chung IM; Kim SH
    Analyst; 2013 Jun; 138(12):3347-55. PubMed ID: 23626987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Accelerator Mass Spectrometry in Human Health and Molecular Toxicology.
    Enright HA; Malfatti MA; Zimmermann M; Ognibene T; Henderson P; Turteltaub KW
    Chem Res Toxicol; 2016 Dec; 29(12):1976-1986. PubMed ID: 27726383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in biomedical applications of accelerator mass spectrometry.
    Hah SS; Henderson PT; Turteltaub KW
    J Biomed Sci; 2009 Jun; 16(1):54. PubMed ID: 19534792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerator mass spectrometry offers new opportunities for microdosing of peptide and protein pharmaceuticals.
    Salehpour M; Ekblom J; Sabetsky V; Håkansson K; Possnert G
    Rapid Commun Mass Spectrom; 2010 May; 24(10):1481-9. PubMed ID: 20411588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomedical applications of accelerator mass spectrometry-isotope measurements at the level of the atom.
    Barker J; Garner RC
    Rapid Commun Mass Spectrom; 1999; 13(4):285-93. PubMed ID: 10097404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current perspectives of 14C-isotope measurement in biomedical accelerator mass spectrometry.
    Lappin G; Garner RC
    Anal Bioanal Chem; 2004 Jan; 378(2):356-64. PubMed ID: 14624324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerator mass spectrometry in pharmaceutical research and development--a new ultrasensitive analytical method for isotope measurement.
    Garner RC
    Curr Drug Metab; 2000 Sep; 1(2):205-13. PubMed ID: 11465084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of a 250 kV single-stage accelerator mass spectrometer with a 5 MV tandem accelerator mass spectrometer--fitness for purpose in bioanalysis.
    Young GC; Corless S; Felgate CC; Colthup PV
    Rapid Commun Mass Spectrom; 2008 Dec; 22(24):4035-42. PubMed ID: 19009519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New frontiers-accelerator mass spectrometry (AMS): Recommendation for best practices and harmonization from Global Bioanalysis Consortium Harmonization Team.
    Young GC; Seymour M; Dueker SR; Timmerman P; Arjomand A; Nozawa K
    AAPS J; 2014 Mar; 16(2):357-9. PubMed ID: 24500278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunities in low-level radiocarbon microtracing: applications and new technology.
    Vuong LT; Song Q; Lee HJ; Roffel AF; Shin SH; Shin YG; Dueker SR
    Future Sci OA; 2016 Mar; 2(1):FSO74. PubMed ID: 28031933
    [No Abstract]   [Full Text] [Related]  

  • 12. Accelerator mass spectrometry of small biological samples.
    Salehpour M; Forsgard N; Possnert G
    Rapid Commun Mass Spectrom; 2008 Dec; 22(23):3928-34. PubMed ID: 18980253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical experience of using human microdosing with AMS analysis to obtain early human drug metabolism and PK data.
    Garner RC
    Bioanalysis; 2010 Mar; 2(3):429-40. PubMed ID: 21083253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of accelerator mass spectrometry for pharmacological and toxicological research.
    Brown K; Tompkins EM; White IN
    Mass Spectrom Rev; 2006; 25(1):127-45. PubMed ID: 16059873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerator mass spectrometry.
    Hellborg R; Skog G
    Mass Spectrom Rev; 2008; 27(5):398-427. PubMed ID: 18470926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological/biomedical accelerator mass spectrometry targets. 1. optimizing the CO2 reduction step using zinc dust.
    Kim SH; Kelly PB; Clifford AJ
    Anal Chem; 2008 Oct; 80(20):7651-60. PubMed ID: 18785761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status and future perspectives of mass spectrometry imaging.
    Nimesh S; Mohottalage S; Vincent R; Kumarathasan P
    Int J Mol Sci; 2013 May; 14(6):11277-301. PubMed ID: 23759983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microdosing for early biokinetic studies in humans.
    Stenström K; Sydoff M; Mattsson S
    Radiat Prot Dosimetry; 2010; 139(1-3):348-52. PubMed ID: 20167793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiocarbon Tracers in Toxicology and Medicine: Recent Advances in Technology and Science.
    Malfatti MA; Buchholz BA; Enright HA; Stewart BJ; Ognibene TJ; McCartt AD; Loots GG; Zimmermann M; Scharadin TM; Cimino GD; Jonas BA; Pan CX; Bench G; Henderson PT; Turteltaub KW
    Toxics; 2019 May; 7(2):. PubMed ID: 31075884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microdosing: a valuable tool for accelerating drug development and the role of bioanalytical methods in meeting the challenge.
    Ings RM
    Bioanalysis; 2009 Oct; 1(7):1293-305. PubMed ID: 21083052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.